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Plasminogen activatorPrevious studies have shown that serine proteases and Rho-associated kinase contribute to carbon
ion radiation-enhanced invasion of the human pancreatic cancer cell line PANC-1. The results pre-
sented here show that nitric oxide synthase (NOS) also plays a critical role in this process. Irradiation
of PANC-1 cells promoted invasion and production of nitric oxide (NO), which activated the
PI3K–AKT signaling pathway, while independently activating RhoA. Inhibition of PI3K, Rho-
associated kinase, and serine protease alone or in conjunction with NOS suppressed the
radiation-enhanced invasion of PANC-1 cells, suggesting that they could serve as possible targets
for the management of tumor metastasis.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).1. Introduction matrix metalloproteinases (MMPs), which remodel the ECM byTumor metastasis is the major cause of cancer-related mortal-
ity, accounting for more than 90% of the deaths [1,2]. A clear under-
standing of the mechanisms underlying metastasis remains elusive
owing to the effects of cumulative mutations in metastatic cells
and the heterogeneity of mutated genes among metastatic cancer
types.
In the ﬁrst step of metastasis, cancer cells migrate into the
extracellular matrix (ECM) using two modes of migration.
Elongated mesenchymal-like cells produce proteases such asproteolysis to create paths for cell migration (mesenchymal mode
of motility). In contrast, rounded amoeboid cells squeeze between
gaps of the matrix proteins by means of bleb-like protrusions, a
movement mediated by actomyosin contractions (amoeboid mode
of motility) [3–5]. Some cell lines derived from tumors utilize both
modes, which differ fundamentally in terms of mechanism, making
it difﬁcult to suppress invasiveness using a single class of reagent.
We previously reported that in two pancreatic cancer-derived
cell lines, MIAPaCa-2 and PANC-1, cells underwent mesenchy-
mal–amoeboid (MA) transition upon exposure to an inhibitor
speciﬁc to either mode of motility [6,7]. Interestingly, these cells
showed differential responses to genotoxic stress induced by pho-
ton (X-ray) irradiation or particle ion beams. Compared to photons,
carbon ion beams deliver a larger mean energy per unit length of
their trajectory [8,9]. The relative biological effectiveness of carbon
ion beams with respect to reference photon radiation is estimated
to be approximately 2–3-fold, as assessed by biological endpoints
such as cell death, DNA damage, and chromosomal aberrations,
among others. [10,11]. In addition, equivalent doses of carbon ions
and photons produce different biological responses in irradiated
cells, for instance, differential gene expression [12]; however, the
speciﬁc mechanisms leading to such differences remain unknown.
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enhanced by X-ray irradiation, but was almost completely sup-
pressed by exposure to carbon ion beams; in contrast, invasion
was enhanced in PANC-1 cells by carbon ion irradiation, but the
enhancement was negligible by X-ray treatment [6,7]. X-ray-
induced invasiveness of MIAPaCa-2 cells was almost completely
suppressed by treatment with Rho-associated coiled-coil-forming
protein kinase (ROCK) or MMP inhibitors, which blocked mesen-
chymal and amoeboid modes of motility, respectively. Carbon
ion-induced PANC-1 cell invasion was suppressed by inhibiting
ROCK and serine protease but not MMP; however, approximately
50% of cells were still able to migrate through the ECM under these
conditions. This limited suppression suggested that an unidentiﬁed
mechanism contributes to carbon ion radiation-induced cell inva-
sion. The objective of the present study was to identify these addi-
tional mechanisms underlying PANC-1 invasiveness in response to
genotoxic stress.
2. Materials and methods
2.1. Cell culture and reagents
The human pancreatic cancer cell lines PANC-1 and MIAPaCa-2,
and the human glioblastoma cell line SF126 were purchased from
the American Type Culture Collection (Manassas, USA) and were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Nissui
Pharmaceutical Co., Ltd.; Tokyo, Japan) supplementedwith 10% fetal
bovine serum (FBS; HyClone; Logan, USA). The nitric oxide synthase
(NOS) inhibitors NG monomethyl-L-arginine (L-NMMA) and
1400W-HCl (Wako; Osaka, Japan), phosphatidylinositol 3-kinase
(PI3K) inhibitors LY294002 (Wako) and wortmannin (Merck;
Darmstadt, Germany), urokinase-type plasminogen activator
(uPA) serine protease inhibitor amiloride hydrochloride hydrate
(Sigma–Aldrich, St. Louis, MO, USA), ROCK inhibitor Y27632 (Wako,
Osaka, Japan), and nitric oxide (NO) donor S-nitrosoglutathione
(GSNO, Santa Cruz Biotechnology Inc.; Santa Cruz, USA) were also
used.
2.2. Irradiation
Cells were irradiated with carbon ion at doses of 0.5, 1, 2, or
4 Gy, as previously described [7]. The initial energy of the carbon
ion beam was 290 MeV/u, with a linear energy transfer value of
80 keV/lm; a mono-energetic beam with a narrow Bragg Peak
was applied at a depth of 10 cm. Radiation was delivered at a dose
rate of approximately 1 Gy/min. An outline of the experimental
procedures is shown in Suppl. Fig. 1.
2.3. Inhibitor screening
The inhibitor library consisting of 285 compounds was provided
by the Screening Committee of Anticancer Drugs library [13]. Cells
were diluted (1  105) and mixed with each compound for a ﬁnal
concentration of 1 lM [13]. Each sample was transferred to a
Transwell membrane on a CultureCoat 96-well BME cell invasion
plate (Trevigen; Gaithersburg, USA), and invasion assays were per-
formed according to the manufacturer instructions. The number of
invaded cells was calculated for each compound based on a stan-
dard curve generated by plotting relative ﬂuorescence units as a
function of the number of PANC-1 cells.
2.4. Immunoblotting
Immunoblotting was performed according to standard methods
[6,7]. Primary antibodies against human nitric oxide synthase
(NOS)1, NOS2 (Santa Cruz Biotechnology Inc.), AKT1 and 2, andphosphorylated (p)-AKT (Cell Signaling Technology; Danvers,
USA), along with horseradish peroxidase-conjugated anti-mouse
IgG or anti-rabbit IgG (Amersham Biosciences; Buckinghamshire,
UK) were used.
To evaluate PI3K-mediated AKT activation in NO donor-treated
cells, cells were cultured for 2 days before the culture medium was
replaced with fresh phenol red-free medium; cells were then incu-
bated with GSNO with or without PI3K inhibitor (LY294002;
1.4 lM) for 24 h. The medium was then collected and used for
NO2 measurements, while cells were washed with PBS and lysed
with RIPA buffer (Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA) for immunoblotting.
To investigate the effect of carbon ion radiation on AKT activa-
tion in the presence or absence of NOS inhibitor, cells were treated
with L-NMMA (3 lM) for 7 h on day 1 after irradiation, washed
with PBS, then lysed with RIPA buffer.
2.5. Immunoﬂuorescence labeling and image acquisition
Cells were cultured on coverslips in DMEM supplemented with
10% FBS for 48 h. The cells were ﬁxed with 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 15 min, then permeated with
0.1% Triton X-100 in PBS for 10 min at room temperature. Cells
were washed with PBS and blocked with 3% fetal calf serum, fol-
lowed by incubation with primary antibody for 30 min at room
temperature. For the primary antibodies, AKT1, AKT2, and p-AKT
used for the immunoblotting, and p-GIRDIN (TAKARA, Shiga,
Japan) were used. After washes in PBS, cells were treated with
Alexa Fluor 555- or 488-labeled anti-mouse IgG or anti-rabbit
IgG secondary antibodies (Invitrogen; Carlsbad, USA). The slides
were washed with PBS and mounted with ProLong Gold Antifade
Reagent containing the nuclear counterstain 40,6-diamidino-2-
phenylindole (DAPI; Invitrogen). Immunostaining of invaded cells
that reached the undersurface of the Transwell membrane was
performed by placing the Transwell directly onto the antibody
solution on Paraﬁlm for 30 min at room temperature. The mem-
branes were cut with a needle and mounted with ProLong Gold
Antifade Reagent.
Cells were visualized and images were acquired using a
BZ-9000 ﬂuorescence microscope and associated software
(Keyence; Osaka, Japan). DAF-2DA-treated NO-producing live cells
stained with DAPI, or ﬁxed cells labeled with Alexa Fluor 555 or
488 were photographed at room temperature using a 20  Plan
ﬂuorescent lens (N.A. 0.45) with BZ ﬁlters for green ﬂuorescent
protein (GFP) and DAPI (live cells), or tetramethylrhodamine-5-
(and-6)-isothiocyanate, GFP, and DAPI (ﬁxed cells). Representative
images were uniformly processed in Adobe Photoshop using the
brightness and contrast tools.
2.6. Cell invasion and viability assays
The invasive potential of PANC-1 cells was examined as previ-
ously described [6,7]. The four randomly selected ﬁelds of invaded
cells reached the undersurface of the Transwell membrane were
photographed and the number of invaded cells in each ﬁeld was
counted under a light microscope. Percentages of viable and dead
cells were determined by ﬂuorescence-activated cell sorting and
by using a cell viability double-staining kit (Dojindo Molecular
Technologies Inc.; Tokyo, Japan). The proportion of viable cells
was calculated by dividing the number of viable cells by the total
number of seeded cells.
2.7. Detection of NO-producing cells
Diaminoﬂuorescein-2 diacetate (DAF-2DA) (Santa Cruz Biotech-
nology Inc.) was used for the detection of NO-producing cells
Table 1
Compounds found to inhibit irradiated PANC-1 invasion by more than 40% in the ﬁrst
screening.
Compound Description
1400W, HCl NOS2 inhibitor
AMT, HCl NOS2 inhibitor
L-NMMA Inhibits NOS1, NOS2, and NOS3
LY294002 PI3K inhibitor
Wortmannin PI3K inhibitor
Tunicamycin GlcNAc phosphotransferase inhibitor
Deoxynojirimycin Alpha-glucosidase I and II inhibitor
ML-7 Myosin light chain kinase inhibitor
AMD3100
octahydrochloride
Antagonist of C–X–C chemokine receptor type 4
(CXCR4)
AG490 Tyrosine kinase inhibitor
Cucurbitacin I Inhibitor for Janus kinase/signal transducer and
activator of transcription 3 (JAK/STAT3) pathway
CA-074 Cathepsin B inhibitor
Cerulenin Fatty acid synthase inhibitor
IKK-2 inhibitor VI IKK-2 inhibitor
Dexamethasone Synthesized corticosteroid
Baﬁlomycin A1 Vacuolar-type (v-type) H + ATPase inhibitor
Anacardic acid Inhibitor of p300- and p300/CBP-associated factor
histone acetyltransferase
IC60211 DNA-PK Inhibitor
GSK-3 inhibitor IX GSK-3 inhibitor
Description of each compound is in reference to the information provided in the
SCADS inhibitor kit (http://gantoku-shien.jfcr.or.jp/).
All compounds were used for assay at the concentration of 1 lM (n = 1).
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washed with Krebs–Ringer phosphate (KRP) buffer, followed by
staining with DAF-2DA with or without L-NMMA in PBS for 1 h.
The cells were then washed with KRP buffer and treated with the
nuclear stain NucBlue (Invitrogen). For detection of NO-producing
invaded cells, a Transwell invasion assay was performed with cells
grown in a 24-well plate; invaded cells that reached the undersur-
face of the Transwell membrane were stained with DAF-2DA. Three
randomly selected ﬁelds were imaged with a ﬂuorescence micro-
scope, and the total number of PANC-1 cells in each ﬁeld was
assessed by counting the number of DAPI-stained nuclei, while
the percentage of NO-producing cells was calculated by dividing
the number of DAF-2DA-positive cells by the total number of cells.
To measure the NO content of the medium, cells were ﬁrst
washed with PBS, then incubated in fresh medium with or without
L-NMMA for 6 h. Cells were washed with KRP buffer and treated
with diaminoﬂuorescein-2 (DAF-2) (Sekisui Medical; Tokyo, Japan)
for 2 h [14]. Fluorescence in the culture medium was measured
using a plate reader (PerkinElmer; Waltham, USA) at wavelengths
of 495 nm and 515 nm for excitation and emission, respectively.
Nitrite (NO2) levels in the medium were measured after growing
cells for 17 h using the NO2/NO3 Assay Kit-FX (Fluorometric)
2,3-Diaminonaphthalene Kit (Dojindo Molecular Technologies Inc.;
Kumamoto, Japan), according to the manufacturer’s protocol [15].
2.8. RhoA activity assay
To measure endogenous small GTPase activity, a RhoA activa-
tion assay kit was used according to the manufacturer’s instruc-
tions (Cell Biolabs Inc.; San Diego, USA). Brieﬂy, cells were lysed
on ice and centrifuged at 4 C for 10 min at 14,000g, and the
supernatant was incubated with Rhotekin RBD-agarose beads at
4 C for 1 h on a rotator. Protein samples were eluted and pro-
cessed for immunoblotting with anti-RhoA antibodies provided
by the kit.
2.9. Statistical analysis
Statistical analyses were performed using the unpaired
Student’s t-test. A P-value <0.05 was considered signiﬁcant.
3. Results
3.1. Carbon ion radiation-enhanced invasiveness is regulated by NOS
and PI3K
The invasive potential of carbon ion-irradiated PANC-1 cells
was assessed in the presence of 1 lM of each compound according
to recommendations of The Screening Committee of Anticancer
Drugs.
The standard curve for the cell invasion assay is shown in Suppl.
Fig. 2. Of the screened compounds, 19 were found to inhibit PANC-
1 cell invasion by more than 40% relative to controls (Table 1).
Among these, several targeted the same molecule, including theTable 2
Compounds found to inhibit irradiated PANC-1 invasion by more than 40% (the second tr
Compound Description
1400W, HCl NOS2 inhibitor
AMT, HCl NOS2 inhibitor
L-NMMA Inhibits all NOS1, NOS2, NOS3
LY294002 PI3K inhibitor
Wortmannin PI3K inhibitor
Tunicamycin GlcNAc phosphotransferase inhibitor
Deoxynojirimycin Alpha-glucosidase I and II inhibitor
All compounds were used for assay at the same concentration used in other in vitro expNOS inhibitors 1400W-HCl, 2-amino-5,6-dihydro-6-methyl-4H-
1,3-thiazine, and L-NMMA; the PI3K inhibitors LY294002 and wort-
mannin; and the glycosylation inhibitors tunicamycin and deoxy-
nojirimycin. To clarify the effects of these seven compounds,
their ability to inhibit invasion at previously reported concentra-
tions was tested (Table 2). Under these conditions, the NOS and
PI3K inhibitors still inhibited invasion to a similar degree; thus,
these concentrations were used in subsequent experiments
(Fig. 1). These data suggest that PANC-1 cell invasion is regulated
by NOS and PI3K; however, the contribution of other enzymes
could not be ruled out, since the conditions of the initial screen
(1 lM concentration) were not optimized for all compounds in
the library.
3.2. Carbon ion radiation-enhanced invasiveness increases the
proportion of NO-producing cells
The maximum suppression of radiation-enhanced PANC-1 cell
invasion (77%) was observed by treatment with the general NOS
inhibitor L-NMMA (Fig. 1). NO production by PANC-1 cells
increased slightly upon irradiation, and this was also suppressed
by treatment with the inhibitor (Fig. 2A). Since NO is an unstable
molecule, cellular nitrite (NO2) levels were also measured to cor-
roborate the presence of NO [16]. As predicted, increased NO2 pro-
duction was observed in PANC-1 cells irradiated at 2 Gy (Fig. 2B),
and the effect was dose-dependent (Suppl. Fig. 3).ial).
Concentration used for the assay % Reduction in invasion
40 lM [37] 59
4.2 nM [38] 42
3 lM [14] 87
1.4 lM [39] 41
5 nM [40] 45
6 lM [41] 6
0.4 mM [42] 0
eriments (n = 3).
Fig. 1. Effect of NOS and PI3K inhibitor treatment on carbon ion-irradiated PANC-1 cell invasion. (A) Number of invaded cells as a fraction of irradiated cells, untreated or
treated with 1400 W (40 lM), L-NMMA (3 lM), LY294002 (1.4 lM), or wortmannin (5 nM). Data are presented as mean ± SDs of triplicate samples. ⁄P < 0.05. (B) Morphology
of untreated or L-NMMA-treated invaded cells at the undersurface of the Transwell membrane. Scale bar: 200 lm.
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time using DAF-2DA. Interestingly, only 4% of cells produced NO
(Fig. 2C and D). This proportion increased to 20% upon irradiation,
an effect that was suppressed following treatment with L-NMMA
(Fig. 2D and E).
To observe whether NO production was correlated with inva-
sion, the fraction of NO-producing cells among those that reached
the undersurface of the Transwell membrane was determined.
Most (90%) of the invaded cells produced NO, and this proportion
was unaffected by irradiation (Fig. 2F and G), suggesting that NO
production is associated with both spontaneous and radiation-
induced invasion. In accordance with the increase in radiation-
induced NO production, the total number of invaded cells was also
higher (Fig. 1A).
Since PANC-1 was the only pancreatic cell line in which inva-
siveness increased as a result of carbon ion irradiation so far, inva-
siveness after the carbon ion irradiation (2 Gy) was assessed in 30
other cell lines derived from other types of tumors. Of these, the
human glioblastoma cell line, SF126, showed an increase in inva-
siveness upon carbon ion irradiation (Suppl. Fig. 4A). Consistent
with what was observed in PANC-1 cells, elevated levels of NO2
were detected in SF126 culture medium (Suppl. Fig. 4B). Thus,
the enhanced NO2 content of SF126 upon carbon ion irradiation
may be related to the increased invasiveness of irradiated SF126.
We previously reported that radiation suppressed MIAPaCa-2,
BxPC-3, and AsPC-1 cell invasion [7]. In the present study,
decreased percentage of NO-producing cells was observed in MIA-
PaCa-2 after carbon ion irradiation (Suppl. Fig. 4C and D). Further-
more, NO2 levels of MIAPaCa-2 culture medium were decreased
upon irradiation (Suppl. Fig. 4E), suggested that decreased NO2
may be related to the reduced invasiveness observed in irradiated
MIAPaCa-2.
3.3. Upregulation of NOS expression and increased invasiveness by
carbon ion irradiation
Increased levels of NOS1 and NOS2 protein were detected in
nearly all invaded PANC-1 cells (Fig. 3A and B), irrespective ofexposure to radiation. NOS expression was also upregulated in
invaded SF126 glioblastoma cells (Suppl. Fig. 5).
3.4. NO-induced, PI3K-dependent AKT activation in PANC-1 cell
invasion
In addition to NOS inhibitors, PI3K inhibitors were also effective
in suppressing radiation-induced PANC-1 cell invasion. To deter-
mine whether NO plays a role in the activation of the serine/thre-
onine-speciﬁc kinase AKT via PI3K, the phosphorylation status of
endogenous AKT was examined in the presence of the NO donor
GSNO. NO2 levels increased in a dose-dependent manner in
GSNO-treated cells, concomitant with the phosphorylation-depen-
dent activation of AKT (Fig. 4A), in accordance with previous
reports [17]. GSNO-dependent AKT activation was abolished in
the presence of PI3K inhibitors, indicating that NO activated AKT
via stimulation of the kinase activity of PI3K (Fig. 4B). Indeed, lev-
els of AKT1 and AKT2 protein were unaltered by GSNO treatment
(Fig. 4C). In addition, GSNO-induced PANC-1 cell invasion was
observed (Fig. 4D). Treatment with GSNO at concentrations of
>6 mM failed to enhance invasiveness, possibly because of an
increase in cell death (Fig. 4E, Suppl. Fig. 6).
AKT was activated at radiation doses of 2 and 4 Gy (Fig. 4F and
G), an effect that was abolished by L-NMMA treatment, indicating
that the effect was dependent on NO production. Interestingly,
the AKT2 protein level was also upregulated at these doses, but this
was unaffected by application of L-NMMA, indicating that AKT2
expression is not induced by NO (Fig. 4F and G). Similar to what
was observed in PANC-1 cells, AKT was activated in SF126 cells
at a radiation dose of 2 Gy and was associated with enhanced inva-
siveness (Suppl. Fig. 7A).
Consistent with NO-dependent activation of AKT, expression of
p-AKT was detected only in invaded PANC-1 or SF126 cell lines
(Fig. 5A, Suppl. Fig. 7B), which also produced high levels of NOS.
AKT2, but not AKT1, primarily localized to the cell membrane
(Fig. 5B, Suppl. Fig. 7C). Interestingly, distribution of p-AKT in
invaded cells was also observed at the cell membrane. Further-
more, we observed that this activation of p-AKT was reduced by
Fig. 2. NO production in non-irradiated and carbon ion-irradiated PANC-1 cells. (A) NO level in the culture medium, without treatment or after treatment with L-NMMA
(3 lM), as measured by DAF-2. RFU, relative ﬂuorescence units. (B) Relative ratios of NO2 content in non-irradiated vs. carbon ion-irradiated cells. Data are presented as
mean ± SD of triplicate samples. ⁄P < 0.05. (C) Representative images of NO-producing cells. Cells treated with DAF-2DA were visualized by green ﬂuorescence. Left, bright
ﬁeld; middle, epiﬂuorescence; right, merged. Scale bars: 200 lm (top), 50 lm (bottom). (D) NO-producing non-irradiated and carbon ion-irradiated cells, untreated or treated
with L-NMMA. NO production was visualized by green ﬂuorescence, with DAPI-stained nuclei emitting a blue signal. Scale bar: 200 lm. (E) Percentages of NO-producing non-
irradiated or carbon ion-irradiated cells, untreated or treated with L-NMMA. (F) Invaded PANC-1 cells at the undersurface of the Transwell membrane treated with DAF-2DA
(green; NO-producing cells) and DAPI (blue). Scale bar: 200 lm. (G) Number of NO-producing invaded cells counted from three randomly selected ﬁelds, divided by the total
number of invaded cells in the same ﬁeld. The percentages of invading non-irradiated and carbon ion-irradiated cells are shown. Data represent the mean ± SD of triplicate
samples. ⁄P < 0.05 vs. control.
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ness upon irradiation and reduced invasion by treatment with
the NOS inhibitor L-NMMA were conﬁrmed and are shown in
Fig. 6B.Recently, the actin-binding AKT substrate GIRDIN was reported
to play a signiﬁcant role in AKT-dependent cell motility [18]. The
phosphorylation of GIRDIN by activated AKT is essential for actin
organization and lamellipodia formation, and is thus required for
Fig. 3. Upregulation of (A) NOS1 and (B) NOS2 protein expression in non-irradiated and carbon ion-irradiated invading PANC-1 cells. Negative controls were incubated with
secondary antibody only. NC_m, negative control labeled with Alexa Fluor 555-conjugated anti-mouse IgG; NC_r, negative control labeled with Alexa Fluor 555-conjugated
anti-rabbit IgG. Scale bar: 50 lm.
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p-GIRDIN was observed at the leading edge of directionally invad-
ing cells: p-GIRDIN-positive cell processes were seen emerging
from a pore in the Transwell membrane and were immunoreactive
for p-AKT (Fig. 5D).
3.5. NOS–PI3K-independent activation of RhoA by NO
We previously showed that carbon ion-irradiated PANC-1 cells
have the ability to undergo MA transition [7]. Among invaded cells,
a higher proportion of cells with a roundmorphology was observed
in cells exposed to radiation than in non-irradiated cells, a differ-
ence that was abolished by inhibiting NOS (Fig. 1B). In accordance
with these morphological changes, RhoA activation was enhanced
in irradiated cells, which was suppressed by NOS inhibitor treat-
ment (Suppl. Fig. 8A). To determine whether the activation of RhoA
is regulated by the NOS–PI3K signaling pathway, irradiated PANC-
1 cells were treated with PI3K inhibitors. No effect on RhoA activa-
tion was observed, suggesting that NO activates RhoA through a
distinct pathway (Suppl. Fig. 8B).
3.6. Suppression of invasive potential by serine protease, PI3K, ROCK,
and NOS inhibition
Treatment of irradiated PANC-1 cells with a PI3K inhibitor
caused a decrease in invasiveness to baseline levels (Fig. 6A). The
combined application of ROCK and PI3K inhibitors, which blocked
NOS-dependent RhoA and PI3K pathways, respectively, suppressedinvasion to a greater degree than either compound alone, indicat-
ing an additive effect. We previously showed that radiation-
induced invasion decreased by approximately 50% upon combined
treatment with inhibitors of uPA and ROCK [7]. Here, combined
application of ROCK, uPA inhibitors, or NOS and uPA inhibitors,
led to a greater inhibition of invasive potential than individual
application of any one of these agents (Fig. 6A and B). These results
suggest that NO produced as a result of genotoxic stress increases
invasiveness of PANC-1 cells via activation of the PI3K–AKT and
RhoA pathways (Fig. 6C).
4. Discussion
Radiation therapy is a standard method of treatment for most
types of cancer, and recent studies have evaluated its efﬁcacy in
pancreatic cancer treatment [19]. However, the successful applica-
tion of any treatment strategy requires a thorough understanding
of resultant physiological changes, whether intended or inadver-
tent. Therefore, better understanding of the mechanism underlying
changes will facilitate the development of treatments to prevent
these effects and further increase the beneﬁt to patients receiving
radiation therapy.
It was previously observed that genotoxic stress resulting from
the high linear energy transfer carbon ion radiation enhanced inva-
siveness of PANC-1 cells through the activation of serine proteases
such as uPA. Treatment with serine protease inhibitor alone
induced MA transition in cells, with cells continuing to invade the
ECM by a protease-independent mechanism. Although inhibition
A C
B
E
D
Fig. 4. PI3K-mediated AKT activation in NO donor-treated PANC-1 cells. (A) Expression of p-AKT, AKT1, and AKT2 was determined by Western blotting after treating cells
with different concentrations of GSNO. NO2 levels were measured as an index of NO production. (B) Effect of treatment with PI3K inhibitor on GSNO (3 mM)-induced AKT
activation, as determined by Western blotting. LY294002 concentration was 1.4 lM. (C) Quantitative densitometric results for p-AKT, AKT1, AKT2 are shown. Data represent
the mean ± SD of triplicate samples. ⁄P < 0.05 vs. control. (D) PANC-1 cells were trypsinized and washed with PBS, then resuspended in serum-free DMEM with the indicated
dose of GSNO and used for the invasion assay, which was performed over 24 h before invaded cells were ﬁxed and stained. Data represent the mean ± SD of triplicate samples.
⁄P < 0.05 vs. control. (E) PANC-1 cells treated with the indicated dose of GSNO were cultured in DMEM supplemented with 10% FBS or serum-free DMEM for 24 h. Cells were
then ﬁxed and stained with Diff-Quick solution (Sysmex, Kobe, Japan). (F) Effect of carbon ion irradiation on AKT activation in the presence or absence of L-NMMA (3 lM), as
determined by Western blotting. (G) Expression levels of p-AKT, AKT1, and AKT2 were measured by quantitative densitometry. Data represent the mean ± SD of triplicate
samples. ⁄P < 0.05 vs. control.
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M. Fujita et al. / FEBS Letters 588 (2014) 3240–3250 3247of both mesenchymal and amoeboid cell motility via the combined
administration of serine protease and ROCK inhibitors decreased
radiation-induced cell invasion, approximately half of cells still
exhibited invasive potential. In this study, NOS was observed to
play a signiﬁcant role in radiation-enhanced invasiveness through
activation of the PI3K–AKT and RhoA signaling pathways, both of
which have been implicated in actin cytoskeleton remodeling
[20]. NOS and uPA are activated in response to genotoxic stress;
plasmin produced by uPA degrades ECM proteins [21], while NO
produced by NOS activates both PI3K and Rho kinase. Accordingly,
simultaneous inhibition of uPA, PI3K, and ROCK, or uPA and NOS,
resulted in almost complete suppression of radiation-induced cell
invasion (Fig. 6).
NO is known to activate PI3K–AKT signaling and prevents
tumor cell apoptosis [17,22]. Furthermore, NO-dependent mecha-
nisms that promote cell survival are induced by ionizing radiation
[23]. While these reports used cell viability as the end-point for
assessing PI3K–AKT pathway activation, the present study demon-
strated that NOS–PI3K–AKT signaling also mediates cell invasion.
Two closely related members of the AKT/PKB family, AKT1 and
AKT2, differ in their physiological roles, with AKT1 regulating pro-
liferation and survival and AKT2 promoting migration and invasion
[20,24]. Due to the presence of highly conserved serine residues,
immunodetection of a speciﬁc, activated AKT family member is dif-
ﬁcult [25]. However, activated AKT1 and AKT2 localize, respec-
tively, to the nucleus and plasma membrane [24,25]; therefore,examining the subcellular localization of AKT could serve as a
means of distinguishing between activated AKT1 and AKT2. In this
study, localization of p-AKT was predominantly associated with
the plasma membrane, with little nuclear staining, implying that
AKT2 is activated in invading PANC-1 cells, consistent with the
known function of AKT2 [20,24].
Distinct populations of invaded PANC-1 cells were observed,
with carbon ion irradiation speciﬁcally enhancing a population of
NO-producing cells. In the SF126 glioblastoma cell line, NOS is con-
stitutively expressed [26], and likely produces higher levels of NO
than pancreatic cell lines. These experiments conﬁrmed that the
expression of NOS proteins was upregulated in invading, compared
to whole culture, SF126 cells, an observation that was also made in
PANC-1 cells. Accordingly, NO2 content increased concomitantly
with SF126 cell invasion upon carbon ion irradiation (Suppl.
Fig. 4). Conversely, irradiation suppressed NO2 formation and inva-
siveness in MIAPaCa-2 cells. Therefore, invasive potential is modu-
lated by NO in a variety of cell types, but the speciﬁc effects differ
signiﬁcantly.
NO has a role in tumorigenesis, including in pancreatic cancer
[27,28], and NOS expression is correlated with tumor stage or met-
astatic progression [29–31] as well as tumor growth and metasta-
sis in a murine mammary tumor model [32]. Tumor cells with high
levels of NOS expression derived from highly metastatic mice
showed strong invasive potential in the Transwell invasion assay,
and lung metastasis in these mice was reduced upon treatment
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C
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Fig. 5. Upregulation of p-AKT in non-irradiated and carbon ion-irradiated invading PANC-1 cells. (A) Relative levels of protein were compared for whole culture and invaded
cells stained with antibodies against AKT1, AKT2, or p-AKT. Scale bar: 50 lm. (B) Representative images of AKT1, AKT2, and p-AKT localization in invaded cells. Arrows
indicate plasma membrane localization of AKT2 and p-AKT. Scale bar: 20 lm. (C) Non-irradiated or carbon ion-irradiated invading cells, untreated or treated with L-NMMA
and labeled with an antibody against p-AKT. Scale bar: 50 lm. (D) Invaded PANC-1 cells were stained with antibodies against p-GIRDIN and p-AKT. Left panel, p-GIRDIN
(green); the second left panel, p-AKT (red); middle two panels, merged images; right panel, phase contrast images. Scale bar: 10 lm.
3248 M. Fujita et al. / FEBS Letters 588 (2014) 3240–3250with the NOS inhibitor L-NMMA, implicating NOS in the metastasis
of tumor cells to the lungs [33]. In cancer patients receiving c-ray
radiotherapy, NOS levels are correlated with post-radiotherapymetastatic progression; moreover, the upregulation of NOS expres-
sion is associated with decreased survival and a greater likelihood
for metastasis in cervical cancer patients receiving radiotherapy
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C
Fig. 6. Effect of the NOS activity on invasive potential of carbon ion-irradiated
PANC-1 cells. (A) Invasion assay performed with the addition of PI3K inhibitor
(LY294002; 1.4 lM), PI3K and ROCK (Y27632; 10 lM) inhibitors, or PI3K, ROCK, and
uPA (amiloride hydrochloride hydrate; 50 lM) inhibitors. (B) Invasion assay
performed with the addition of NOS (L-NMMA; 3 lM) or uPA inhibitor, or both.
Data represent the mean ± SD of triplicate samples. ⁄P < 0.05 vs. control. (C) Model
of events leading from carbon ion radiation-enhanced genotoxic stress to PANC-1
invasion.
M. Fujita et al. / FEBS Letters 588 (2014) 3240–3250 3249[34]. However, in other cases, patients who experienced tumor
recurrence and metastasis after c-ray radiotherapy had reduced
expression of NOS [35]. Additional studies are therefore required
to clarify these discrepancies. Furthermore, there have been
no studies investigating the correlation between NOS expression
and clinical outcomes in cancer patients receiving carbon ion
radiotherapy.
In contrast to PANC-1, we found that carbon ion irradiation sup-
pressed NO production and invasiveness in MIAPaCa-2 cells. Themolecular basis for these differences is unclear, although heteroge-
neity in the genetic background of cell lines could be an underlying
cause. Mutations in the oncogenes P53 and KRAS have been identi-
ﬁed in both PANC-1 and MIAPaCa-2 pancreatic cells [36]; however,
cell-line speciﬁc mutations in other oncogenes from commercially
available cancer panels have not been found (data not shown).
Whole exon/genome analysis of various cell lines using next-
generation sequencing could be useful for characterizing differen-
tial mutation patterns. In addition, further studies are required to
identify the characteristics of cells that increase NOS activity,
which could provide an explanation for why only a fraction of cells
increases NO production in response to genotoxic stress. Moreover,
several groups have reported that a high concentration of NO can
induce apoptosis in cancer cells. In this study, we showed that rel-
atively high doses of carbon ion radiation and high concentrations
of NO caused cell death, but it was not possible to distinguish
whether this was the result of DNA damage or NO-induced apop-
tosis. Resolving these issues will provide insight into the mecha-
nisms of cancer metastasis, and enable the development of less
toxic therapies to inhibit cancer progression.Acknowledgments
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